Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Risk for use of antidepressants, anxiolytics, and hypnotics in partners of glioma patients-A nationwide study covering 19 years of prescriptions

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Sexual and romantic challenges among young Danes diagnosed with cancer: Results from a cross-sectional nationwide questionnaire study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Body image mediates the effect of cancer-related stigmatization on depression: A new target for intervention

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Kind of blue: A systematic review and meta-analysis of music interventions in cancer treatment

    Research output: Contribution to journalReviewResearchpeer-review

  1. Community-based football in men with prostate cancer: 1-year follow-up on a pragmatic, multicentre randomised controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Correction: Educational delay and attainment in persons with neurofibromatosis 1 in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Maria R N Jansson
  • Annika von Heymann-Horan
  • Birthe K Rasmussen
  • Vanna Albieri
  • Kirsten Frederiksen
  • Nis Suppli
  • Susanne O Dalton
  • Christoffer Johansen
  • Pernille E Bidstrup
View graph of relations

OBJECTIVE: Suffering from malignant brain tumor is a stressful condition, for patients and their partners. In a retrospective cohort study using nationwide registries, we examined partners' risk for first use of antidepressants, anxiolytics, or hypnotics.

METHODS: We followed all 4373 partners of adults with glioma, diagnosed in 1998 to 2013 in Denmark and a cohort of 43 808 partners of glioma-free persons matched 1:10. In Cox proportional hazard models, we estimated hazard ratios (HRs) for a first prescription of psychotropic medications (antidepressants, anxiolytics, or hypnotics) according to the partner's glioma status. Among partners of glioma patients, we further estimated HRs for a first prescription of psychotropic medication according to disease characteristics, sociodemographic factors, and bereavement.

RESULTS: Two years after diagnosis, 29% of female and 21% of male partners of glioma patients had had a first prescription of psychotropic medication compared with 10% in female and 8% in male partners of glioma-free persons. Partners of glioma patients had a significantly increased, 4-fold higher risk for a first prescription of psychotropic medications in the first year after diagnosis than partners of glioma-free persons (HR 4.10, 95% CI, 3.80:4.43). Among partners of glioma patients, the risk was significantly reduced in bereaved compared with non-bereaved partners.

CONCLUSIONS: We have documented, for the first time, that the psychological impact of a diagnosis of glioma is such a severe stress exposure that it increases the risk for having medication prescribed to treat symptoms of anxiety, sleep problems, and depression.

Original languageEnglish
JournalPsycho-Oncology
Volume27
Issue number8
Pages (from-to)1930-36
ISSN1057-9249
DOIs
Publication statusPublished - 2018

ID: 54658690